Oxford, UK-based Alethio Therapeutics, a biopharmaceutical company developing novel treatments for myeloproliferative ...
USA-based SQ Innovation has struck a long-term supply agreement with Italian active pharmaceutical ingredient (API) ...
UK-based STORM Therapeutics, a biotech targeting RNA modifications to reprogram cells and develop novel cancer therapies, has ...
US health technology assessor the Institute for Clinical and Economic Review (ICER), in collaboration with Verdant Research, ...
US biotech Terremoto Biosciences, a firm developing highly-targeted small molecule medicines, has announced the closing of a ...
Japanese drugmaker Daiichi Sankyo says it has agreed to transfer all of its shares in Daiichi Sankyo Healthcare (DSHC), a ...
In what looks to be the largest follow-on stock offering in biopharma history, US oncology company Revolution Medicines ...
German innovation hub BioMed X has launched its first research team in France, partnering with French pharma Servier to ...
US-based Sonire Therapeutics has secured $18 million in Series A financing to advance clinical development of its ...
The US Food and Drug Administration will ask outside advisers in July whether some peptide substances should be allowed on ...
German drugmaker Bayer (BAYN: DE) has highlighted publication of full results from its Phase III OCEANIC-STROKE trial in the ...
UK-based specialty pharma company CNX Therapeutics today announced the appointment of David Flint as chief corporate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results